Questions about the usefulness of FOODTEST results
In this article
  1. Author: Dr Károly Krkos, laboratory medicine specialist
  2. The concept of food intolerance
  3. Food allergy
  4. Intolerance not caused by food allergy
  5. Coeliac disease
  6. Non-coeliac gluten sensitivity (NCGS)
  7. How are IgG antibodies against food components produced?
  8. Absorption of food
  9. Some characteristics of antigen–antibody binding
  10. The reliability of IgG antibody measurement

Author: Dr Károly Krkos, laboratory medicine specialist

The concept of food intolerance

Food intolerance is not a term used consistently even in professional circles. In fact, any condition in which symptoms can be linked to eating food may be called food intolerance. On this basis, food intolerance is a broad umbrella term that includes food allergy, histamine sensitivity, lactose intolerance, fructose malabsorption, complaints caused by other components found in foods (e.g. glutamate, phenylethylamine, etc.) and the disputed IgG intolerance.

Food allergy

The symptoms of food allergy are characteristic (skin and gastrointestinal symptoms, and in severe cases breathing difficulty and circulatory collapse) and develop shortly after the triggering food is eaten, so the trigger can be suspected. The mechanism by which the condition develops is known and accepted as proven. The key factor in the process is that IgE-type antibodies are produced against various food components (primarily proteins). The condition can be diagnosed in the laboratory by measuring antibodies of this type.

Intolerance not caused by food allergy

Many chronic diseases are known whose symptoms can be reduced by following a special diet. These include not only gastrointestinal conditions but also, among others, chronic skin diseases and psychiatric disorders (J Sarris et al.: Lancet Psychiatry 2015, 2:271-274, http://dx.doi.org/10.1016/S2215-0366(14)00051-0), and they can be improved significantly with diet, although the triggering foods are difficult to identify. One way of identifying the triggering foods is an elimination diet: strictly leaving out one food for 1 week while monitoring symptoms, then leaving out a further food and recording symptoms. If several different foods are responsible for triggering the condition, this process can take months, requires great patience and is easy to get wrong. Measuring IgG produced against food components makes it possible to put together a diet that significantly improves the patient’s symptoms without trial and error, under the guidance of a dietitian or nutrition expert. For example, in the treatment of irritable bowel syndrome it is accepted that the patient’s condition can be improved by changing the diet. One way of setting up the diet is to base it on identifying IgG-reactive foods. Some specialists try everything to improve the patient’s condition and already know from experience that an elimination diet can bring significant improvement.

There is, however, one disease whose symptoms are not very characteristic and whose diagnosis is very important: coeliac disease (true gluten sensitivity). Lifelong, continuous gastroenterological follow-up is essential for people with proven coeliac disease.

Coeliac disease

(Source: Benjamin Lebwohl, David S Sanders, Peter H R Green: The Lancet 2018, 391: 70-81 http://dx.doi.org/10.1016/S0140-6736(17)31796-8)

Coeliac disease – true gluten sensitivity – affects about 1% of the population. The trigger is the protein component of cereals called gluten, which consists of the giant molecule glutenin and the much smaller protein gliadin. The latter is the less digestible and more reactive component.

When should coeliac disease be confirmed or ruled out?

  • Persistent abdominal or gastrointestinal symptoms that cannot be explained otherwise
  • Faltering growth
  • Unexpected weight loss
  • Severe or persistent mouth ulcers
  • Unexpected iron, vitamin B12 or folic acid deficiency
  • Type 1 diabetes
  • Autoimmune thyroid disease
  • Irritable bowel syndrome (IBS)
  • First-degree relative of a patient with coeliac disease

When should testing for coeliac disease be considered?

  • Metabolic bone disease (osteoporosis or osteomalacia)
  • Unexplained neurological symptoms (mainly peripheral nerve disease or unsteady gait)
  • Unexplained raised temperature, recurrent miscarriage
  • Persistently raised liver enzyme levels of unknown origin
  • Dental enamel defects
  • Down syndrome
  • Turner syndrome

If true gluten sensitivity is suspected, specific serological tests (transglutaminase IgA, deamidated gliadin IgA, EMA IgA antibody) must always be performed. In IgA deficiency – which is more common among people with coeliac disease – the IgG versions of all these tests are also measured. The results of other serological tests (other antibodies, e.g. gliadin, reticulin antibodies, etc.) may be positive, but such positivity can also occur in other diseases, i.e. they do not prove coeliac disease and are not specific to it), and they become positive in a much smaller percentage of true patients than the specific tests mentioned above, i.e. they are not sensitive enough to diagnose the disease. To confirm the condition, small-intestinal biopsy from defined sites and histological examination of the samples are also required. The diagnosis is clear if one of the serological tests and the histological examination are both positive (a similar histological picture can also occur in other conditions). According to the position of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), in children whose specific serological test (e.g. transglutaminase IgA antibody) reaches or exceeds 10 times the positive cut-off, and in whom another test measuring a different specific antibody (EMA IgA antibody) on a sample from a separate blood draw gives a similarly high result, coeliac disease can be considered proven even without a biopsy. In other cases and in adults, a biopsy is considered necessary for the diagnosis alongside the blood tests. In doubtful cases (e.g. negative serology, positive histology), a genetic test (HLA typing) helps, because if the predisposition cannot be shown, the disease can practically be ruled out. It must be emphasised that these methods are only reliable while gluten is being eaten. If someone has been on a gluten-free diet, they need to eat gluten for a defined period before the investigation (according to current criteria, at least 3 g of gluten a day for a minimum of 2 weeks). The biopsy is performed at the end of this period if the symptoms point to the disease. Serological tests can be expected to become positive 4 weeks after the start of this diet. A strict gluten-free diet and continuous gastroenterological monitoring are indispensable for coeliac patients, which is why the condition must be ruled out or confirmed before any diet is started. Medicines are also being tried in treatment – these are currently at the experimental stage.

Non-coeliac gluten sensitivity (NCGS)

Over the past two decades, a great deal of data has been published showing that a gluten-free diet can significantly improve a patient’s condition even in the absence of true gluten sensitivity. If coeliac disease and gluten allergy can be ruled out and a gluten-free diet brings significant improvement, the condition is non-coeliac gluten sensitivity (NCGS). Some gastroenterologists regard this condition as a category of irritable bowel syndrome (IBS). It has been suggested that in such cases not only gluten but other cereal proteins may also play a role in causing the complaints. In some patients, leaving out certain carbohydrates and sugar alcohols (the so-called FODMAP diet) also helps, while for others leaving out gluten-containing cereals is the solution. At present the condition can only be diagnosed by exclusion, but in about half of these patients the anti-native-gliadin IgG antibody is positive (as confirmed by numerous studies published in high-quality professional journals). FOODTEST includes this parameter. Measurement of anti-native-gliadin antibodies (AGA IgA and IgG) has long been used in laboratory practice in the diagnosis of autoimmune diseases.

How are IgG antibodies against food components produced?

While the development of food allergy is clearly proven, the interpretation of how other antibodies arise is still debated, even though studies on the details of this process have appeared in many high-quality journals. The players in the process are the gut (absorption), the immune system (tolerance or defence) and the enormous mass of microbes living in the gut (the microbiota, whose genetic material is the microbiome).

Sources:

Absorption of food

The epithelial cells of the small intestine play the main role in absorbing food. Between the cells there is a protein structure that blocks the way in (the so-called tight junction), which only lets through small molecules and positively charged ions. Small molecules and molecular units do not provoke an attack by the immune system. A large proportion of the large molecules in food are broken down into their subunits by enzymes in the digestive system. These do not provoke a defence reaction either. Undigested molecules that enter the absorptive cells are partly broken down into smaller pieces. Inside the cell, they bind to certain proteins found in the cell that take part in defence processes. Large molecules that pass through in this way prompt the immune system not to attack but to accept them (tolerance). According to more recent data, undigested protein molecules enter not only through the absorptive cells but also through the mucus-producing goblet cells. Protein entry by this route also results in tolerance.

Fasano’s research showed that epithelial cells can produce a molecule (which he named zonulin) that leads to the breakdown of the structure between epithelial cells, and the larger molecules that flood in there prompt the immune system to attack. A similar consequence occurs when, in certain pathological conditions (e.g. iron deficiency), defence-triggering proteins bound by antibody molecules pass intact through the absorptive epithelium.

The gut-associated lymphoid tissue (GALT) detects the molecules that trigger defence and ultimately initiates the production of various types of antibodies (including IgG molecules).

There are 4 subclasses of IgG-type antibodies, IgG1, IgG2, IgG3 and IgG4 (numbered according to their concentration in the blood). IgG4 is present in the smallest amount. The first food intolerance tests to be produced measured IgG4 molecules only. However, research in recent years has shown that this molecule does not take part in the final destruction of the invading component perceived as dangerous. Many inflammation-inducing molecules are produced in this step. IgG4 therefore tends rather to try to dampen overly prolonged immune reactions that may harm the body, as well as allergic processes. For this reason, the European Academy of Allergy and Clinical Immunology (EAACI) emphasised in its methodological letter that the IgG4 test is not suitable for determining an elimination diet. Tests that measure IgG4 only are often positive even when someone eats a given food frequently and in large amounts. Many have generalised this position to tests that measure total IgG levels, such as FOODTEST 200+. In fact, IgG1, IgG2 and IgG3 can activate the body’s complement protein system, which results in the production of inflammation-inducing molecules and thus in complaints. Histological preparations have shown that in intolerant patients the food protein–IgG complex activates the complement system.

In summary, a food component that has not been properly digested can provoke inflammation once it enters the body. One trigger of this process may be the IgG antibody produced against the food component.

Some characteristics of antigen–antibody binding

Although antibodies bind to a particular part of a given protein or other large molecule (the so-called antigen epitope), they may also be able to bind to similar protein components found in distant species. This is called cross-reaction. Its practical significance is well known from allergology. For example, someone with a dust allergy may well react with similarly violent allergic symptoms to eating invertebrates (seafood: mussels, crustaceans, octopus, squid). Another example: people sensitive to ragweed are advised not to eat members of the gourd family (pumpkin, melon, courgette, cucumber), sunflower seeds or bananas while the plant is in flower. These phenomena are known primarily in connection with common inhaled allergens. They are less well mapped for foods that come into view less often and for other substances that are consumed. For example, ginkgo may cross-react with the cashew family (smoke tree, mango, pistachio, cashew, sumac – a spice used in Middle Eastern cuisine), and poppy seed with sesame seed, hazelnut, rye, buckwheat, kiwi and birch pollen.

Besides the fact that the antibody produced may bind to different molecules, it must also be taken into account that a given large molecule has several antigen epitopes, i.e. different antibody molecules can bind to different reactive parts of the molecule. Proteins take on a characteristic spatial structure, often like a ball of yarn. Only the surface of the intact protein comes into the view of the immune system. If this structure changes as a result of some influence (e.g. heat), i.e. the molecule unfolds, the more deeply buried epitope may prompt the immune system to react and produce antibodies. Heat-treated molecules are therefore not immunologically identical to the native molecule. In the FOODTEST 200+ test, the position labelled “puliszka” (polenta) contains a nixtamalised maize extract. In nixtamalisation, maize kernels are cooked in a mildly alkaline solution (dilute slaked lime solution), then washed and dried. The extract found here therefore differs in immunoreactivity from the one at the position labelled “maize”. If either is positive in the evaluation, it is advisable to leave maize-containing foods out of the diet. Similarly, couscous and wheat also differ immunologically. If either is positive, leaving it out is recommended.

Another unusual feature of the FOODTEST 200+ test is that, because of the particular chemical properties of gliadin, it does not end up in the extracts of gliadin-containing cereals. The reason is that the food extracts fixed in the test are prepared as aqueous extracts, whereas gliadin dissolves only in alcohol. It is therefore listed separately. This is why gliadin may be negative while one of the gliadin-containing cereals (e.g. wheat) is positive: this means that the antibody was produced against another protein of that cereal. It can also happen that gliadin is positive and none of the cereals are. This means that the antibody was produced against gliadin, and in this case it is advisable to leave all gliadin-containing cereals out of the diet (even though they gave a negative result in the test).

The number of articles on the importance of the microbiota has been growing steadily over the past decade. A healthy gut flora is an ecological system that suppresses pathogenic components and supplies the gut and the body with nutrients and important biologically active molecules. Medicines (not only antibiotics, but also drugs that affect stomach acid production and anti-inflammatory/pain-relieving drugs) can upset the balance and lead to the overgrowth of pathogenic components, contributing to the development of many diseases.

The current position on acceptable facts

According to the current professional position, only statements supported by evidence-based data can be accepted. The methodology of proof was in fact developed to test the effects of medicines: so-called double-blind studies must be carried out in a carefully pre-planned (prospective) way, on many people and at several centres, and their results published in a recognised medical journal. This means that the participants of the patient and control groups are selected by statistical methods by a team that is not involved in evaluating the study. Within both groups studied, some patients receive a tablet containing the real active substance and others a tablet that looks identical but contains no active substance. The effect is evaluated by a team that does not know who received the real tablet and who received the “dummy” one. The results are evaluated using appropriate statistical methods.

On the one hand, this kind of procedure requires that the patient group studied suffer from a single, reliably diagnosed disease (a homogeneous patient group). Selecting a healthy control group is not easy either, because people who appear healthy may be in a very early stage of a disease, before symptoms appear. People with IgG intolerance do not belong to a single disease group (participants would have to be recruited separately for each symptom group). Checking adherence to a double-blind diet (i.e. eating food that looks, feels, tastes and has the same texture, but either contains or does not contain a given food) would practically require continuous, individual dietitian support, and the studies would have to be carried out not only for each symptom group but also for each food to be left out, one by one. All this would involve so much work and cost that it is questionable whether such a study will be carried out in the near future. No literature can be found on testing the effect of a dietary intervention in this way that is beyond criticism one way or another. One example is testing the effect of a casein-free and gluten-free diet in autistic children. In this case, the studies were carried out on patients belonging to a clearly diagnosed disease group. Until the 2010s, no truly high-level studies on the subject were published, as confirmed by the meta-analysis in the Cochrane Database of Systematic Reviews that reviewed such articles (C. Millward et al, doi: 10.1002/14651858.CD003498.pub3). The ScanBrit study (Neuroscience, 13:2, 87-100, DOI: 10.1179/147683010X12611460763922), carried out with the participation of several Scandinavian and British centres, met almost every criterion, except that a double-blind diet was not used during the study. It showed clearly that the diet is effective when followed for an appropriate length of time. The truly double-blind study published afterwards refutes the effectiveness of the diet. The latter can be faulted not only for performing statistical calculations and drawing conclusions on the basis of a very small number of patients (which is unacceptable), but also because the challenge with gluten and casein took place once a week, which is an unacceptably short period for assessing the effect of these foods, since this is clearly not an allergic reaction. Furthermore, the introduction of the article reveals the author’s bias. Of the earlier studies, which were far from adequate in quality, it extols those showing no effect and is entirely negative about those showing an effect.

It is a fact that no prospective, randomised, double-blind study demonstrating the effectiveness of an elimination diet based on an IgG test has been published, but its unsuitability has not been demonstrated either. The reaction triggered by IgE molecules (the interaction of cells, the release of numerous bioactive substances) cannot be seen, and proof of its existence does not depend on everyday personal experience and conviction but on experimental results. Similarly, it cannot be claimed that the existence of IgG and its role in disease processes is simply clearly improbable and need not be proven because that is obvious. Just as adequate data are available on reactions triggered by IgE, there are also convincing data (supported by histological images) on the role IgG plays in disease processes.

The reliability of IgG antibody measurement

The principle of FOODTEST 200+ is entirely similar to that of the tests that detect classic food allergy. To detect IgE that reacts with food, the given food extract is reacted with the patient’s serum. In this phase, every type of antibody produced against the food (IgG, IgA, IgM, IgE) binds to the given food component, if the patient has produced any. In the next step, in allergy tests, incubation takes place with a second antibody that reacts only with IgE molecules and carries a signal molecule. In the end, a “sandwich” (food component – IgE-type antibody produced against the food component – labelled anti-IgE antibody) forms in the test tube, and its labelled component makes it possible to measure the amount of IgE molecules produced in the patient that can be held responsible for allergic symptoms. The difference between FOODTEST 200+ and allergy tests is essentially that the signal antibody is directed against IgG molecules, so it detects IgG molecules instead of IgE antibody molecules. The reliability of every measurement can be ensured with control samples (one giving a value in the negative range and one giving a value in the positive range). A further step in demonstrating reliability is that an external company specialising in checking analytical systems sends an unknown sample to the laboratory. The laboratory measures it with its own method and sends the result back to the company, from which it receives an evaluation of how reliable its test was. FOODTEST 200+ meets all the criteria mentioned above; moreover, the control samples and the so-called calibrators needed to determine the quantitative data are checked for every patient. In addition, every food appears in duplicate on the microchip used for the test, so reliability can also be checked food by food. The test requires a manual technique that takes at least 3 hours to perform. This is followed by an individual check, which takes a further half to one hour.

The debate is therefore not about the reliability of the measurement but about the evaluation of the results. The official position is currently rigid rejection, despite the supporting experimental evidence. It is well known from the history of science that it takes a long time for an entrenched opinion (see the experience gained with the early IgG4 tests) to change.

So if you have chronic complaints, first of all have yourself examined by a specialist appropriate to your group of symptoms. If factors that significantly impair your quality of life cannot be eliminated with medicines or other interventions, and it seems that you could improve your condition by changing your diet, the FOODTEST 200+ result can help in designing the right diet. It is definitely worth asking a dietitian for help with this. A poorly designed diet can lead to deficiency diseases. A balanced elimination diet, on the other hand, can significantly improve the patient’s condition without side effects.

Dr Károly Krkos

27 May 2019

Book a food intolerance test

Food intolerance

Don't just get the school bag ready

Starting school is not only about new exercise books and a changed daily routine but also about reorganising family meals. The FOODTEST Children's pac...

Food intolerance

IBS and food intolerance: can diet help?

Several factors may lie behind irritable bowel syndrome, and the role of diet may also come up. The article explains in plain terms how certain foods...

Related articles